Lebanon entered the third week of its coronavirus disease (COVID-19) vaccination campaign on Monday, with stores and malls reopening for the first time since the closure on Jan. 21. But warnings about reopenings are being heard from the country’s medical experts. The director of the Hariri Governmental University Hospital, Dr. Firas Al-Abyad, said “we are fooling ourselves because the reality is different.” Statistics published by the Ministry of Health show that the average number of daily recorded cases remains above 3,000 and the average number of deaths is hovering above 40. The total number of recorded COVID-19 cases in Lebanon was 372,792 as of Saturday, while 4,652 deaths were recorded during the same period. Medical professionals have claimed that the vaccination campaign is going as slow “as a turtle.” The vaccination of 11 MPs at the parliament, which was not in line with the vaccination process taking place at hospitals, was another violation that has sparked outrage among the public. Health Ministry adviser Mohammed Haidar said that “the slow vaccination process is due to the small number of vaccines that arrive every week and that need to be distributed to all the hospitals. Around 100,000 doses of the Pfizer vaccine have arrived in Lebanon so far, while 300,000 doses of the AstraZeneca vaccine are expected to arrive this month.” Lebanon received a loan from the World Bank to purchase 2.2 million doses, of which 28,080 doses arrived in the first week, 31,590 doses arrived in the second week, and 41,300 doses arrived on Saturday. The health minister had revealed that “Moderna had notified Lebanon a while ago that it will not be able to conclude any agreement in order to provide the country with its products because it had previous commitments to marketing its products in five countries only. However, it is ready for its agreement to take effect starting January 2022.” The ministry believes that the 2,730,000 vaccine doses that have been reserved will be enough to vaccinate 20 percent of Lebanon’s population. According to the national plan, 249,000 are expected to be used during the first quarter of the year, while the remaining doses are to be divided into three batches to cover the rest of the year. However, the number of those who were vaccinated during the first two weeks based on the national platform, meaning the medical and nursing staff along with the elderly over the age of 75, constitute less than 3 percent of the targeted group.